when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health

Carboplatin Pfizer

Carboplatin (carboplatin)

Metastatic Ovarian Cancer

DASATINIB (DASATINIB)

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)

Bcr/Abl fusion protein

Xspray Pharma AB

LENALIDOMIDE (LENALIDOMIDE)

Follicular Lymphoma

CRL4(CRBN) E3 ubiquitin ligase

page 4 of 62

131

Bristol-Myers Squibb Co

2 catalysts

NELARABINE (NELARABINE)

$AMRXAmneal Pharmaceuticals, Inc.

Onureg (azacitidine)

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)

Bristol-Myers Squibb Co

TOREMIFENE CITRATE

TOREMIFENE CITRATE (TOREMIFENE CITRATE)

Metastatic Breast Cancer

Rising Pharma Holdings Inc

Unloxcyt (cosibelimab-ipdl)

Cutaneous Squamous Cell Carcinoma (cSCC)

Checkpoint Therapeutics Inc

denosumab biosimilar

Jubereq (denosumab-dssb)

Post Menopausal Osteoporosis

Luye Pharma Group Ltd

pre_registration

Imfinzi (durvalumab)

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)

Programmed cell death 1 ligand 1

$AZNASTRAZENECA PLC

imetelstat sodium

Rytelo (imetelstat sodium)

Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)

Telomerase reverse transcriptase

$GERNGERON CORP

Yervoy (ipilimumab)

Esophageal Squamous Cell Carcinoma (ESCC)

Bristol-Myers Squibb Co

lenvatinib mesylate

Lenvima (lenvatinib mesylate)

Renal Cell Carcinoma

Vascular endothelial growth factor receptor

revumenib citrate

Revuforj (revumenib citrate)

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)

$SNDXSyndax Pharmaceuticals Inc

Imdelltra (tarlatamab-dlle)

Small-Cell Lung Cancer

teverelix [INN]

Prostate Cancer

Hernexeos (zongertinib)

Non-Small Cell Lung Cancer

Boehringer Ingelheim Corp

Bortezomib Pfizer

Bortezomib (bortezomib)

Mantle Cell Lymphoma

Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)

CLADRIBINE (CLADRIBINE)

Relapsing Remitting Multiple Sclerosis (RRMS)

DECITABINE (DECITABINE)

Chronic Myelomonocytic Leukemia (CMML)

Mylan Institutional Inc

Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)

Molecular Targeting Technologies Inc

Squamous Non-Small Cell Lung Cancer

Shanghai Henlius Biotech Inc

HYDROCORTISONE SODIUM SUCCINATE

HYDROCORTISONE SODIUM SUCCINATE (HYDROCORTISONE SODIUM SUCCINATE)

Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease)

IDELALISIB (IDELALISIB)

Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform

$GILDGILEAD SCIENCES, INC.

Jelmyto (mitomycin)

Transitional Cell Carcinoma (Urothelial Cell Carcinoma)

$URGNUroGen Pharma Ltd.

LOMUSTINE (LOMUSTINE)

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)

Carnegie Pharmaceuticals LLC

NILOTINIB (NILOTINIB)

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)

Tyrosine-protein kinase ABL1Bcr/Abl fusion protein

Xspray Pharma AB

Metastatic Colorectal Cancer

Bristol-Myers Squibb Co

Metastatic Pancreatic Cancer

Rise Biopharmaceutical Ltd

pre_registration

apatinib mesylate

CAM-RIVO (apatinib mesylate)

Hepatocellular Carcinoma

Vascular endothelial growth factor receptor 2

Elevar Therapeutics Inc